Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 214 Show results per page	View Search Criteria \| Help With Results

Last Modified: 11/13/2008 First Published: 8/1/1998


1.		Phase II Study of Observation in Patients With Favorable Low-Grade Glioma and a Phase III Study of Radiotherapy With or Without Procarbazine, Lomustine, and Vincristine in Patients With Unfavorable Low-Grade Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				NCI				RTOG-9802 E-R9802, NCCTG-R9802, SWOG-R9802, RTOG-DEV-1012, NCT00003375, RTOG-98-02


2.		Phase II-III Chemotherapy with BLEO/DTIC/VBL/ADR/PRED or NM/VCR/PCB/PRED Plus Radiotherapy for Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								DFCI-75100

Last Modified: 5/23/2007


3.		Phase II/III Chemotherapy with MVP (MITO/VBL/CACP) vs CHIP vs CBDCA vs VBL/CACP vs MVP-CAMP (MITO/VBL/CACP/CTX/ADR/MTX/PCB) in Patients with Metastatic (Stage III) non-Small Cell Bronchogenic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-1583


4.		Phase II/III Chemotherapy with CAMP (CTX/ADR/MTX/PCB) vs VP-16/DAVA/CACP vs VP-16/CACP vs DAVA/CACP for Stage III Metastatic non-Small Cell Bronchogenic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 70								UCCRC-3248 NCI-D81-014-080

Last Modified: 6/1/1995


5.		Phase III Randomized Study of Chemotherapy with ChlVPP (CLB/VBL/PRDL/PCB) Alternating with PABlOE (PRDL/DOX/BLEO/VCR/VP-16) vs PABlOE Alone for Hodgkin's Disease (Summary Last Modified 06/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 69								CRC-TU-HO3001 EU-93029

Last Modified: 9/1/1994


6.		Phase III Randomized Study of Intensive PCV (PCB/CCNU/VCR) Given Prior to Radiotherapy vs Upon Recurrence in Adults with Supratentorial Anaplastic Astrocytoma (Summary Last Modified 09/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 16								EORTC-26921

Last Modified: 7/20/2007


7.		Phase III Randomized Study of Radiotherapy with vs without BUDR and Followed by PCV (PCB/CCNU/VCR) for Anaplastic Astrocytomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				RTOG-9404 NCCTG-947251, SWOG-9340, RTOG-94-04

Last Modified: 4/4/2008 First Published: 7/1/1994


8.		Phase III Randomized Study of Radiotherapy With or Without Intensive Procarbazine, Lomustine, and Vincristine (PCV) in Patients With Unifocal or Multifocal, Supratentorial, Pure or Mixed Anaplastic Oligodendroglioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				RTOG-9402 CAN-NCIC-CE2, E-R9402, NCCTG-927252, SWOG-9402, INT-0149, NCT00002569, CE2

Last Modified: 6/6/2005


9.		Phase III Study of Adjuvant Low-Dose Involved-Field Radiotherapy vs No Adjuvant Therapy in Children with Hodgkin's Disease in CR Following Chemotherapy Assigned by Clinical Stage (Summary Last Modified 02/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 21 at diagnosis				NCI				CCG-5942


10.		Phase III Pilot Study of Alternating Courses of MOPP and ABDV plus Radiotherapy with or without Levamisole for Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified								MSKCC-75104

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute